🎉 ECLLA Club Programme 2026 Launch! Join Our First Educational Session “CLL Essentials, Diagnostics & Treatment Pathways” | July, 29th – REGISTRATION OPEN
Dear ECLLA Members, We are delighted to announce the official launch of the ECLLA Club Programme 2026 and to invite you to our first session, CLL Essentials, Diagnostics & Treatment Pathways. This interactive session combines an expert-led presentation with...🎥 Recordings Now Available: ECLLA Multi-Stakeholder Discussion on Time Off Treatment in CLL
The European CLL Association (ECLLA) is pleased to announce that recording of the multi-stakeholder panel discussion, “Time Off Treatment in CLL – Clinical Control and Patient Priorities in Fixed-Duration Treatment,” is now available to watch online. Held...
ECLLA Co-Founder Jan Rynne Joins European Discussion on the EU Biotech Act
ECLLA is proud to share that our Co-Founder, Jan Rynne, recently joined the Cancer Patients Europe (CPE) Policy Webinar as a panellist to discuss the EU Biotech Act and its potential to improve clinical trials and access to innovative cancer treatments across Europe....
